Pascal Soriot covid-19 reports testing vaccine Pascal Soriot

Covid-19 vaccine 'won't be ready for second wave' says Oxford professor as trial restarts

Reading now: 256
www.dailystar.co.uk

Covid-19  vaccine at Oxford University started suffering from a neurological disease that prompted developers AstraZeneca to order a “global shutdown” of all tests.

The company’s chief executive, Pascal Soriot, reportedly told investors that the woman who had volunteered to take part in the trials was showing signs of an as yet undiagnosed neurological problem.In the same call, reports medical news site Statnews, Soriot revealed that the trial also had to be suspended July after one test subject started experiencing neurological problems.

Read more on dailystar.co.uk
The website celebsbar.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA